Biogen Announces Positive CHMP Opinion For VUMERITY - Quick Facts
17/9 15:51
(RTTNews) - Biogen Inc. (BIIB) announced the Committee for Medicinal Products for Human Use has recommended granting marketing authorization for VUMERITY in the European Union. VUMERITY is a next-generation oral fumarate for the treatment of adults with relapsing-remitting multip...